you are here:

RPG Life Sciences Ltd.

BSE: 532983 | NSE: RPGLIFE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE105J01010 | SECTOR: Pharmaceuticals

BSE Live

May 14, 16:00
429.05 -15.00 (-3.38%)
Volume
AVERAGE VOLUME
5-Day
6,635
10-Day
11,898
30-Day
13,812
9,003
  • Prev. Close

    444.05

  • Open Price

    444.40

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

May 14, 15:59
431.35 -12.10 (-2.73%)
Volume
AVERAGE VOLUME
5-Day
66,564
10-Day
123,908
30-Day
182,984
47,552
  • Prev. Close

    443.45

  • Open Price

    443.60

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    431.35 (590)

ANNOUNCEMENTS ON RPG Life

  • May 01, 2021 13:03 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Newspaper Publication

    In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Audited Financial Results for the quarter and year ended March 31, 2021. Kindly take this information on record.

  • Apr 30, 2021 23:02 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    Please find enclosed herewith a copy of press release with respect to Audited Financial Results of the Company for the financial year ended March 31, 2021. Kindly take the above on record.

  • Apr 30, 2021 18:28 Source: BSE

    RPG Life Sciences - Corporate Action-Board approves Dividend

    Recommended equity dividend of Rs. 7.20 per share of Rs. 8/- each (90%) for the financial year ended March 31, 2021, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting

  • Apr 30, 2021 18:21 Source: BSE

    RPG Life Sciences - Audited Financial Results For The Quarter And Year Ended March 31, 2021

    Audited Financial Results of RPG Life Sciences Limited, for the quarter and year ended March 31, 2021, approved and taken on record by the Board of Directors of RPG Life Sciences Limited at its meeting held on April 30, 2021 along with Auditors Report thereon with unmodified opinion. The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m.

  • Apr 30, 2021 18:11 Source: BSE

    RPG Life Sciences - Outcome Of The Board Meeting Held On April 30, 2021

    Outcome of the meeting of the Board of Directors of RPG Life Sciences Limited held on April 30, 2021, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m.

  • Apr 27, 2021 19:28 Source: BSE

    RPG Life Sciences - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

    Sr. No. Particulars Details
    1Name of CompayRPG LIFE SCIENCES LTD.
    2CINL24232MH2007PLC169354
    3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00
    4Highest Credit Rating during the previous FY NA
    4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
    5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE


    We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No



    Name of the Company Secretary: Rajesh Shirambekar
    Designation: Company Secretary & Compliance Officer
    EmailId: rajesh.shirambekar@rpgls.com
    Name of the Chief Financial Officer: Vishal Shah
    Designation: Chief Financial Officer
    EmailId: vishal.shah@rpgls.com

    Date: 27/04/2021

    Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

  • Apr 24, 2021 14:32 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Newspaper Publication

    In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper notice published to give intimation of the meeting of Board of Directors of the Company scheduled to be held on April 30, 2021, inter alia, to consider and approve the audited financial results for the quarter and year ended March 31, 2021 and to recommend dividend, if any, for the financial year March 31, 2021. Kindly take this information on record.

  • Apr 23, 2021 16:46 Source: BSE

    RPG Life Sciences - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31, 2021.

    RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2021 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations, 2015'), this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday, April 30, 2021, inter-alia, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2021. Further, pursuant to the 'Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders' of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from April 1, 2021 and will continue to remain closed till 48 hours after the results are made public on April 30, 2021. Kindly take this information on record.

  • Apr 22, 2021 12:10 Source: BSE

    RPG Life Sciences - Clarification On Increase In Volume

    With reference to your above referred email dated April 22, 2021 seeking clarification on significant increase in the volume of security across Exchanges in the recent past, we wish to inform you that there are no events, information, announcements etc. that have a bearing on the operations/performance of the Company which includes price sensitive information, which is required to be disclosed to the stock exchanges pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Hence, we are unable to comment on the significant increase in the volume of Company's security across Exchanges, in the recent past. Further, we would like to reiterate that, as in the past, the Company would continue to inform stock exchanges regularly about any price sensitive information and to make it available on the website of the Company before the same is made public. Kindly request you to take the same on record.

  • Apr 22, 2021 11:34 Source: BSE

    RPG Life Sciences - Clarification sought from RPG Life Sciences Ltd

    The Exchange has sought clarification from RPG Life Sciences Ltd on April 22, 2021, with reference to Movement in Volume.The reply is awaited.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Apr 30, 2021
Remark : Audited Results